Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Market Capitalization (2011 - 2026)

Talphera (TLPH) posted Market Capitalization of $77.8 million for Q2 2026, up 48.56% on a QoQ basis from $52.4 million in Q1 2026, and up 389.76% year-over-year from $15.9 million in Q2 2025.

Analysis

Talphera (TLPH) Market Capitalization (2011 - 2026) Analysis & Trends

Talphera has reported Market Capitalization for 16 years, with the latest figure at $77.8 million in Q2 2026.

  • On a quarterly basis, Market Capitalization rose 389.76% year-over-year to $77.8 million in Q2 2026; TTM through Jun 2026 was $77.8 million, a 389.76% increase from a year earlier, with the FY2025 full-year figure at $56.2 million, up 318.42% from the prior year.
  • Market Capitalization was $77.8 million for Q2 2026 at Talphera, up from $52.4 million in the prior quarter.
  • The five-year high for Market Capitalization was $77.8 million in Q2 2026, with the low at $7.2 million in Q1 2023.
  • Average Market Capitalization over 5 years is $28.3 million, with a median of $22.9 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Market Capitalization plunged 83.1% in 2023, then soared 389.76% in 2026.
  • Over 5 years, Market Capitalization stood at $18.6 million in 2022, then plunged by 32.67% to $12.5 million in 2023, then climbed by 7.14% to $13.4 million in 2024, then soared by 318.42% to $56.2 million in 2025, then surged by 38.34% to $77.8 million in 2026.
  • The last three Market Capitalization figures came in at $77.8 million (Q2 2026), $52.4 million (Q1 2026), and $56.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.79 Mn
Mar 31, 2026 52.37 Mn
Dec 31, 2025 56.23 Mn
Sep 30, 2025 40.57 Mn
Jun 30, 2025 15.88 Mn
Mar 31, 2025 13.13 Mn
Dec 31, 2024 13.44 Mn
Sep 30, 2024 22.54 Mn
Jun 30, 2024 23.32 Mn
Mar 31, 2024 25.46 Mn
Dec 31, 2023 12.54 Mn
Sep 30, 2023 9.83 Mn
Jun 30, 2023 12.20 Mn
Mar 31, 2023 7.21 Mn
Dec 31, 2022 18.63 Mn
Sep 30, 2022 31.11 Mn
Jun 30, 2022 35.36 Mn
Mar 31, 2022 42.66 Mn
Dec 31, 2021 76.62 Mn
Sep 30, 2021 121.70 Mn